4Zhong X, Seshire A, Huster B, et al. Arsenic hut not all-trans retinoic acid overcomes the aberrant stem cell capacity of PMI.lRARalpha?positive leukemic stem cells. Haematologioa, 2007, 92: 323-331.
5Zhang XW, Yan X], Zhou ZR, et al. Arsenic trioxide controls the fate of the PML-RARaipha onooprotein hy directly binding PML. Science, 2010,328: 240-243.
6Sanz MA, Montesinos P, Vellenga E, et al. Hisk-adapied treatment of acute promyelocytic leukemia with all-trans rr-tinor acid and anthracyr-line monochemotherapy: long-term outcome of the LPA 99 multicenter studv hy the PETHEMA Group. Biood. 2008,J J 2: 3130- 3134.
7Ad" s L, Sam MA, Chvret S, et al. Treatment of newly diagnosed acute prornyelocytic leukemia (APL): a comparison of French-Belgian?Swiss and PETHEMA results, Blood, 2008, 111: 1078-1084.
8Lengfelder E, Haferlach C, Saussele S, et al. High dose Ara-C in the treatment of newly diagnosed acute promyelocytir- leukemia: long-term results of the German AMLCG. Leukemia, 2009, 23: 2248-2258.
